Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress, page-20

Wasa
Because the trials etc take so long, people simply become bored with IMU many have held this share for a really long time and as a result have just simply become tempted to sell, this in my view is why the price is held low ( I don't buy the idea expressed by a few on this forum that its mostly caused by manipulation but I admit that could sometimes be the case, but I think all in all we give too much belief in the manipulation idea than is actually reality)

That being said, as I see that the fundamentals as outlined over the last three years in any of the announcements, Imugene has it seems to me to only have strengthened and substantially de-risk this technology.

Really hoping and expecting it will be good news that Leslie brings (as previously indicated) sometime this month.

It would be a real bummer for my overweight holding if Imugene decide due to bad results to shut the whole thing down.

That being said, my view is still positive,and when, I get the jitters (which with an early stage Bio tech investment is only natural) I go back and re-read and scrutinise Imugene's announcements, doing this reminds me and helps me remember why I invested here in the first place.
the only caveat to re-reading those old announcements however is, not only do they give me back my confidence to hold I usually find myself unable to resist buying more, (even got a few more last week at 2.3 cents )and as a result by some measures, some might say I have ended up a little overweight in this stock.
fp